Batrachochytrium dendrobatidis is a fungal pathogen in the phylum Chytridiomycota that causes the skin disease chytridiomycosis. Chytridiomycosis is considered an emerging infectious disease linked to worldwide amphibian declines and extinctions. Although amphibians have well-developed immune defenses, clearance of this pathogen from the skin is often impaired. Previously, we showed that the adaptive immune system is involved in the control of the pathogen, but B. dendrobatidis releases factors that inhibit in vitro and in vivo lymphocyte responses and induce lymphocyte apoptosis. Little is known about the nature of the inhibitory factors released by this fungus. Here, we describe the isolation and characterization of three fungal metabolites produced by B. dendrobatidis but not by the closely related nonpathogenic chytrid Homolaphlyctis polyrhiza. These metabolites are methylthioadenosine (MTA), tryptophan, and an oxidized product of tryptophan, kynurenine (Kyn). Independently, both MTA and Kyn inhibit the survival and proliferation of amphibian lymphocytes and the Jurkat human T cell leukemia cell line. However, working together, they become effective at much lower concentrations. We hypothesize that B. dendrobatidis can adapt its metabolism to release products that alter the local environment in the skin to inhibit immunity and enhance the survival of the pathogen.
In recent years, amphibian populations around the world have declined due, in part, to the emerging fungal disease chytridiomycosis, caused by Batrachochytrium dendrobatidis (1-6). Heavily infected frogs show lethargy, loss of appetite, and behavioral changes (1,3,7,8), and they die due to a failure to maintain a balance of essential ions across the damaged skin (9). Although amphibians have robust and complex immune defenses (10), immune responses against this pathogen are impaired (11-13). Our previous studies showed that sublethal X irradiation of South African clawed frogs (Xenopus laevis) resulted in decreased lymphocyte numbers in the spleen and increased fungal burdens, demonstrating that lymphocyte-mediated adaptive immune responses are important for control of the infection (14). Further studies demonstrated that B. dendrobatidis cells release molecules that inhibit proliferation of lymphocytes and transformed cell lines and induce apoptosis of lymphocytes (11). Enriched fungal supernatants also interfere with the development of a delayed-type hypersensitivity (DTH)-like response to injected phytohemagglutinin (PHA) in X. laevis (12). Thus, the inhibitory factors can act locally in the skin environment. The nature of these inhibitory molecules has not previously been determined. Using liquid chromatography coupled with mass spectrometry (LC-MS) and UVvisible (UV-Vis) detection, we isolated three small-molecule metabolites from B. dendrobatidis supernatants (B. dendrobatidis Sup) with putative immunomodulatory activity. These metabolites are methylthioadenosine (MTA), tryptophan, and an oxidized product of tryptophan, kynurenine (Kyn). The ...